Effect of sorafenib on cisplatin-based radiochemotherapy in head and neck cancer cells

被引：0
|
作者：
Moeckelmann, N. [1 ]
Kriegs, M. [2 ]
Rothkamm, K. [2 ]
Dikomey, E. [2 ]
Knecht, R. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Klin Hals Nasen Ohrenheilkunde Kopf & Halschirurg, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Lab Strahlenbiol & Expt Radioonkol, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0214
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [31] Cisplatin-based chemotherapy: the only alternative in chemoradiation of head and neck cancer? Experience of the Institute of Oncology, Ljubljana, Slovenia
    Strojan, Primoz
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2007, 12 (06) : 329 - 337
  • [32] Use of cystatin C as a marker to detect renal insufficiency in head and neck cancer patients with cisplatin-based chemotherapy
    Boelke, E.
    Gripp, S.
    Matuschek, C.
    Hermsen, D.
    Peiper, M.
    Budach, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer
    Lu, Hsueh-Ju
    Yang, Chao-Chun
    Wang, Ling-Wei
    Chu, Pen-Yuan
    Tai, Shyh-Kuan
    Chen, Ming-Huang
    Yang, Muh-Hwa
    Chang, Peter Mu-Hsin
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [34] RELATIVE CONTRIBUTIONS OF RADIATION AND CISPLATIN-BASED CHEMOTHERAPY TO SENSORINEURAL HEARING LOSS IN HEAD-AND-NECK CANCER PATIENTS
    Hitchcock, Ying J.
    Tward, Jonathan D.
    Szabo, Aniko
    Bentz, Brandon G.
    Shrieve, Dennis C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (03): : 779 - 788
  • [35] Definitive radiotherapy versus radiochemotherapy with weekly docetaxel in patients with head and neck cancer and cisplatin intolerance
    Schmalz, Claudia
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (09) : 869 - 870
  • [36] Definitive radiochemotherapy with weekly cisplatin in patients with head and neck cancer; single institution outcome analysis
    Pala, M.
    Odrazka, K.
    Holeckova, P.
    Vitek, P.
    Kubes, J.
    Dvorak, J.
    Podlesak, T.
    JOURNAL OF BUON, 2012, 17 (03): : 471 - 477
  • [37] Radiochemotherapy with amifostine cytoprotection for head and neck cancer
    J. Büntzel
    Julius Schuth
    Klaus Küttner
    Michael Glatzel
    Supportive Care in Cancer, 1998, 6 : 155 - 160
  • [38] Radiochemotherapy with amifostine cytoprotection for head and neck cancer
    Buntzel, J
    Schuth, J
    Kuttner, K
    Glatzel, M
    SUPPORTIVE CARE IN CANCER, 1998, 6 (02) : 155 - 160
  • [39] Amifostine in simultaneous radiochemotherapy for head and neck cancer
    Buntzel, J
    Kuttner, K
    Frohlich, D
    Schuth, J
    Glatzel, M
    OTO-RHINO-LARYNGOLOGIA NOVA, 1997, 7 (04) : 204 - 210
  • [40] Intensified radiochemotherapy with amifostine in head and neck cancer
    Buntzel, J
    Glatzel, M
    Weinaug, R
    Schuth, J
    Frohlich, D
    Kuttner, K
    ANNALS OF ONCOLOGY, 1998, 9 : 75 - 76
12345